These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 39038744)

  • 1. Inclusion of harm outcomes in core outcome sets requires careful consideration.
    Tay J; Robinson C; Blazeby J; Loke Y; Lowery A; Alkhaffaf B; Kirkham JJ
    J Clin Epidemiol; 2024 Oct; 174():111474. PubMed ID: 39038744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study found increasing use of core outcome sets in Cochrane systematic reviews and identified facilitators and barriers.
    Saldanha IJ; Hughes KL; Dodd S; Lasserson T; Kirkham JJ; Wu Y; Lucas SW; Williamson PR
    J Clin Epidemiol; 2024 May; 169():111277. PubMed ID: 38428540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient participation impacts outcome domain selection in core outcome sets for research: an updated systematic review.
    Dodd S; Gorst SL; Young A; Lucas SW; Williamson PR
    J Clin Epidemiol; 2023 Jun; 158():127-133. PubMed ID: 37054902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review of core outcome sets (COS) developed for different settings finds there is a subset of outcomes relevant for both research and routine care.
    Kearney A; Williamson PR; Dodd S
    J Clin Epidemiol; 2024 Sep; 173():111440. PubMed ID: 38936556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement was needed in the standards of development for cancer core outcome sets.
    Gargon E; Williamson PR; Blazeby JM; Kirkham JJ
    J Clin Epidemiol; 2019 Aug; 112():36-44. PubMed ID: 31009657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Core Outcome Set-STAndards for Development: The COS-STAD recommendations.
    Kirkham JJ; Davis K; Altman DG; Blazeby JM; Clarke M; Tunis S; Williamson PR
    PLoS Med; 2017 Nov; 14(11):e1002447. PubMed ID: 29145404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A scoping review of core outcome sets and their 'mapping' onto real-world data using prostate cancer as a case study.
    Meregaglia M; Ciani O; Banks H; Salcher-Konrad M; Carney C; Jayawardana S; Williamson P; Fattore G
    BMC Med Res Methodol; 2020 Feb; 20(1):41. PubMed ID: 32103725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methods used in the selection of instruments for outcomes included in core outcome sets have improved since the publication of the COSMIN/COMET guideline.
    Gorst SL; Prinsen CAC; Salcher-Konrad M; Matvienko-Sikar K; Williamson PR; Terwee CB
    J Clin Epidemiol; 2020 Sep; 125():64-75. PubMed ID: 32470621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Representation of published core outcome sets in practice guidelines.
    Rhodes S; Dodd S; Deckert S; Vasanthan L; Qiu R; Rohde JF; Florez ID; Schmitt J; Nieuwlaat R; Kirkham J; Williamson PR
    J Clin Epidemiol; 2024 May; 169():111311. PubMed ID: 38423401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COS-STAR: a reporting guideline for studies developing core outcome sets (protocol).
    Kirkham JJ; Gorst S; Altman DG; Blazeby J; Clarke M; Devane D; Gargon E; Williamson PR;
    Trials; 2015 Aug; 16():373. PubMed ID: 26297658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving core outcome set development: qualitative interviews with developers provided pointers to inform guidance.
    Gargon E; Williamson PR; Young B
    J Clin Epidemiol; 2017 Jun; 86():140-152. PubMed ID: 28495644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment highlights need for improvement in standards of development of core outcome sets for rare genetic diseases.
    Ciucă A; Banka S; Newman WG; Moldovan R; Kirkham JJ
    J Clin Epidemiol; 2023 Sep; 161():84-93. PubMed ID: 37423316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. More than half of systematic reviews have relevant core outcome sets.
    Saldanha IJ; Dodd S; Gorst SL; Williamson PR
    J Clin Epidemiol; 2021 Aug; 136():168-179. PubMed ID: 33974970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Core outcomes in nerve surgery: development of a core outcome set for ulnar neuropathy at the elbow.
    Wilson TJ; Davis GA; Dengler NF; Guedes F; Hébert-Blouin MN; Jack MM; Jacques LG; Kretschmer T; Mahan MA; Midha R; Pondaag W; Puffer RC; Rasulic L; Ray WZ; Rizk E; Rodriguez-Aceves CA; Shapira Y; Smith BW; Socolovsky M; Spinner RJ; Zager EL
    J Neurosurg; 2024 Feb; 140(2):489-497. PubMed ID: 37877978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survey indicated that core outcome set development is increasingly including patients, being conducted internationally and using Delphi surveys.
    Biggane AM; Brading L; Ravaud P; Young B; Williamson PR
    Trials; 2018 Feb; 19(1):113. PubMed ID: 29454368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pediatric core outcome sets had deficiencies and lacked child and family input: A methodological review.
    Goren K; Monsour A; Stallwood E; Offringa M; Butcher NJ
    J Clin Epidemiol; 2023 Mar; 155():13-21. PubMed ID: 36528231
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.